NCT00389363View on ClinicalTrials.gov

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Asthma
Interventions
DRUG

ALK HDM tablet

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT00389363 - Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects | Biotech Hunter | Biotech Hunter